Organon & Co. (OGN)
13.79
+0.05
(+0.36%)
USD |
NYSE |
Oct 07, 16:00
13.78
-0.01
(-0.07%)
Pre-Market: 20:00
Organon Price to Book Value : 3.600 for Oct. 7, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 07, 2026 | 3.600 |
| October 06, 2026 | 3.587 |
| October 05, 2026 | 3.576 |
| October 02, 2026 | 3.582 |
| October 01, 2026 | 3.579 |
| September 30, 2026 | 3.576 |
| September 29, 2026 | 3.587 |
| September 28, 2026 | 3.584 |
| September 25, 2026 | 3.584 |
| September 24, 2026 | 3.582 |
| September 23, 2026 | 3.584 |
| September 22, 2026 | 3.576 |
| September 21, 2026 | 3.571 |
| September 18, 2026 | 3.571 |
| September 17, 2026 | 3.574 |
| September 16, 2026 | 3.568 |
| September 15, 2026 | 3.566 |
| September 14, 2026 | 3.563 |
| September 11, 2026 | 3.561 |
| September 10, 2026 | 3.558 |
| September 09, 2026 | 3.568 |
| September 08, 2026 | 3.589 |
| September 04, 2026 | 3.597 |
| September 03, 2026 | 3.595 |
| September 02, 2026 | 3.595 |
| Date | Value |
|---|---|
| September 01, 2026 | 3.592 |
| August 31, 2026 | 3.592 |
| August 28, 2026 | 3.592 |
| August 27, 2026 | 3.592 |
| August 26, 2026 | 3.595 |
| August 25, 2026 | 3.589 |
| August 24, 2026 | 3.589 |
| August 21, 2026 | 3.589 |
| August 20, 2026 | 3.587 |
| August 19, 2026 | 3.584 |
| August 18, 2026 | 3.571 |
| August 17, 2026 | 3.576 |
| August 14, 2026 | 3.582 |
| August 13, 2026 | 3.582 |
| August 12, 2026 | 3.566 |
| August 11, 2026 | 3.563 |
| August 10, 2026 | 3.555 |
| August 07, 2026 | 3.550 |
| August 06, 2026 | 3.537 |
| August 05, 2026 | 3.542 |
| August 04, 2026 | 3.540 |
| August 03, 2026 | 3.540 |
| July 31, 2026 | 3.537 |
| July 30, 2026 | 3.537 |
| July 29, 2026 | 3.534 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Merck & Co., Inc. | 8.406 |
| Pfizer Inc. | 1.873 |
| Bristol Myers Squibb Co. | 5.465 |
| Harmony Biosciences Holdings, Inc. | 2.288 |
| ANI Pharmaceuticals, Inc. | 2.767 |
Price to Book Value Related Metrics
| PE Ratio | 17.67 |
| PS Ratio | 0.5932 |
| Price to Free Cash Flow | 6.513 |
| Price | 13.79 |
| Earnings Yield | 5.66% |
| Market Cap | 3.621B |
| Operating PE Ratio | 3.057 |
| Normalized PE Ratio | 9.112 |